Clinical Trial Details

EORTC-24061

Back to Clinical Trials Database

Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategies

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 11-Feb-2008
Date Step1 close: 17-May-2010
Date Step2 close: 17-May-2010
Data management at EORTC Yes
Design Phase 2
Randomized open
Targeted Sample size All Groups: 55
Treatment Fluorouracil, Cetuximab, Carboplatin, Cisplatin, Docetaxel
Study Staff
Type of cancer
Participating groups EORTC Head and Neck Cancer Group
Participating centers
Protocol summary http://clinicaltrials.gov/ct/show/NCT00646659
NCT number NCT00646659
EudraCT 2006-004189-14